Inovio Pharmaceuticals, Inc. (INO)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Inovio Pharmaceuticals, Inc. To Contact The Firm 

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ:INO) of the May 12, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. 

If you invested in Inovio stock or options between February 14, 2020 and March 9, 2020 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to  

The lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of all those who purchased Inovio common stock between February 14, 2020 and March 9, 2020 (the “Class Period”).  The case, McDermid v. Inovio Pharmaceuticals, Inc. et al., No. 2:20-cv-01402 was filed on March 12, 2020, and has been assigned to Judge Gerald J. Pappert.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements about the Company’s development of a purported vaccine for the novel coronavirus and its ability to begin human trials as early as April 2020. 

On March 9, 2020, Citron Research published the following statement on Twitter about the Company: "SEC should immediately HALT this stock and investigate the ludicrous and dangerous claim that they designed a vaccine in 3 hours. This has been a serial stock promotion for years. This will trade back to $2 investors have been warned."

On this news, the Company's stock price fell from an intraday high of $19.36 per share on March 9, 2020 to a close of $5.70 per share on March 10, 2020: a $13.66 or 70.56% drop. 

Contact us

Inovio Pharmaceuticals, Inc. (INO)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.


Filed on 03/18/2020


Lead Plaintiff Deadline 05/12/2020


685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331


Richard W. Gonnello Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania